PMID- 10475192 OWN - NLM STAT- MEDLINE DCOM- 19990921 LR - 20151119 IS - 0140-6736 (Print) IS - 0140-6736 (Linking) VI - 354 IP - 9180 DP - 1999 Aug 28 TI - Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphism confers susceptibility to thyroid associated orbitopathy. PG - 743-4 AB - Smoking and demographic variables are known to be risk factors for the development of thyroid-associated orbitopathy (TAO) among patients with Graves' hyperthyroidism, but a firm genetic basis for TAO has not been established. We show that the presence and severity of TAO are associated with an allele of the cytotoxic T lymphocyte antigen-4-gene. FAU - Vaidya, B AU - Vaidya B FAU - Imrie, H AU - Imrie H FAU - Perros, P AU - Perros P FAU - Dickinson, J AU - Dickinson J FAU - McCarthy, M I AU - McCarthy MI FAU - Kendall-Taylor, P AU - Kendall-Taylor P FAU - Pearce, S H AU - Pearce SH LA - eng GR - Wellcome Trust/United Kingdom PT - Letter PT - Research Support, Non-U.S. Gov't PL - England TA - Lancet JT - Lancet (London, England) JID - 2985213R RN - 0 (Antigens, CD) RN - 0 (Antigens, Differentiation) RN - 0 (CTLA-4 Antigen) RN - 0 (CTLA4 protein, human) RN - 0 (Genetic Markers) RN - 0 (Immunoconjugates) RN - 7D0YB67S97 (Abatacept) SB - IM CIN - Lancet. 1999 Nov 20;354(9192):1824. PMID: 10577673 MH - Abatacept MH - Adolescent MH - Adult MH - Aged MH - Aged, 80 and over MH - Alleles MH - Antigens, CD MH - Antigens, Differentiation/*genetics MH - CTLA-4 Antigen MH - Child MH - Female MH - Genetic Markers/genetics MH - Genetic Predisposition to Disease/*genetics MH - Graves Disease/*genetics/immunology MH - Humans MH - *Immunoconjugates MH - Male MH - Middle Aged MH - Polymorphism, Genetic/*genetics MH - Risk Factors MH - T-Lymphocytes, Cytotoxic/*immunology EDAT- 1999/09/04 09:00 MHDA- 2000/02/19 09:00 CRDT- 1999/09/04 09:00 PHST- 1999/09/04 09:00 [pubmed] PHST- 2000/02/19 09:00 [medline] PHST- 1999/09/04 09:00 [entrez] AID - S0140-6736(99)01465-8 [pii] AID - 10.1016/S0140-6736(99)01465-8 [doi] PST - ppublish SO - Lancet. 1999 Aug 28;354(9180):743-4. doi: 10.1016/S0140-6736(99)01465-8.